Subsidiary Guarantors - Condensed Consolidating Statement of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (14,001)	$ (4,120)
Investing Activities
Capital expenditures	(1,361)	(738)
Supply center acquisition	(348)	0
Proceeds from sale of assets	1	4
Net cash used in investing activities	(1,708)	(734)
Financing Activities
Borrowings under ABL facilities	44,672	30,073
Payments under ABL facilities	(32,378)	(31,560)
Intercompany transactions	0	0
Equity contribution from parent	0	80
Net cash provided by (used in) financing activities	12,294	(1,407)
Effect of exchange rate changes on cash and cash equivalents	(47)	101
Net (decrease) increase in cash and cash equivalents	(3,462)	(6,160)
Cash and cash equivalents at beginning of period	9,594	11,374
Cash and cash equivalents at end of period	6,132	5,214
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(5,962)	(6,942)
Investing Activities
Capital expenditures	(1,294)	(507)
Supply center acquisition	(348)
Proceeds from sale of assets	1	4
Net cash used in investing activities	(1,641)	(503)
Financing Activities
Borrowings under ABL facilities	30,174	15,500
Payments under ABL facilities	(28,389)	(22,500)
Intercompany transactions	4,609	11,719
Equity contribution from parent		80
Net cash provided by (used in) financing activities	6,394	4,799
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	(1,209)	(2,646)
Cash and cash equivalents at beginning of period	7,320	7,855
Cash and cash equivalents at end of period	6,111	5,209
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Supply center acquisition	0
Proceeds from sale of assets	0	0
Net cash used in investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Intercompany transactions	0	0
Equity contribution from parent		0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(2,079)	10,759
Investing Activities
Capital expenditures	(10)	(25)
Supply center acquisition	0
Proceeds from sale of assets	0	0
Net cash used in investing activities	(10)	(25)
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Intercompany transactions	2,089	(10,729)
Equity contribution from parent		0
Net cash provided by (used in) financing activities	2,089	(10,729)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	0	5
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	5
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(5,960)	(7,937)
Investing Activities
Capital expenditures	(57)	(206)
Supply center acquisition	0
Proceeds from sale of assets	0	0
Net cash used in investing activities	(57)	(206)
Financing Activities
Borrowings under ABL facilities	14,498	14,573
Payments under ABL facilities	(3,989)	(9,060)
Intercompany transactions	(6,698)	(990)
Equity contribution from parent		0
Net cash provided by (used in) financing activities	3,811	4,523
Effect of exchange rate changes on cash and cash equivalents	(47)	101
Net (decrease) increase in cash and cash equivalents	(2,253)	(3,519)
Cash and cash equivalents at beginning of period	2,274	3,519
Cash and cash equivalents at end of period	$ 21	$ 0